About Emmanouil Karagiannis
Form D filings for Amaryllis Therapeutics in 2024 list Emmanouil Karagiannis as director.
Emmanouil Karagiannis first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Emmanouil Karagiannis in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Emmanouil Karagiannis works with at each company, as listed on that company's latest Form D.
Amaryllis Therapeutics, Inc. · Form D, Sep 18, 2024
JK
Jeongseuk Kang
Chief Executive Officer and director